Who owns OnKure Therapeutics?
1 of the world’s richest people holds OnKure Therapeutics in our tracked profiles.
About
OnKure Therapeutics is a clinical-stage biotech developing small molecule drugs that target specific disease-causing mutations in cancer. Its lead candidate, OKI-219, targets a mutated form of PI3Kα.
Source: OnKure Therapeutics, Inc. annual report (10-K) (filed 2026-03-12) ↗. Summary in our own words.
Billionaire holders
- Len BlavatnikMediaStakeOnKure Therapeutics - 13D via AI Biotechnology LLC (incl. pre-funded warrants, capped by blocker) · 19.99% · as of Mar 2026source ↗
Each row is a sourced entry from that person’s profile. Stakes are as of the date shown, not today.
Recent SEC filings
No Form 4 insider trades in OnKure Therapeutics from the holders above in the last 90 days.
Form 4 insider trades post within 2 business days. New to filings? Read Filings 101.
Recent moves
No digest stories about OnKure Therapeutics yet. The archive grows every morning.
Related
Other companies held by the same people.